Caduet is a combination drug prescribed to treat various conditions that affect the heart and blood vessels. This eMedTV article describes the drug in detail, offering information on its effects, side effects, dosing guidelines, and more.
Most people have no problems when taking Caduet. Side effects are possible, however, so this eMedTV Web page lists the commonly reported ones, the rare ones, and the side effects that should be reported immediately to your healthcare provider.
Caduet uses, as this eMedTV segment explains, are concerned with treating a variety of conditions that affect the heart and blood vessels. The specific effects of the components of the drug are discussed, as are off-label uses.
Various factors affect a person's Caduet dosage, which this eMedTV segment describes. General dosing guidelines are also explained, and helpful tips and suggestions are included for those taking the prescription medication.
Drug interactions can occur if Caduet is combined with spironolactone and fibrates, among other things. This eMedTV resource describes these Caduet drug interactions in detail, including the problems they can cause and how they may be avoided.
Knowing Caduet warnings and precautions can help ensure a safe treatment process, so this eMedTV page provides several of the most common. This includes people who should not take the drug and things to discuss with your doctor prior to treatment.
This segment of the eMedTV library explores the effects and symptoms of a Caduet overdose. Factors that can affect symptoms are explained, a list of likely symptoms is given, and available treatment options are discussed, such as giving IV fluids.
This eMedTV article takes a look at issues surrounding Caduet and pregnancy. It explains why the FDA gave it a Category X rating, how the safety of drugs during pregnancy is rated, and compares the benefits and risks of taking the drug when pregnant.
This page of the eMedTV library takes an in-depth look at Caduet and breastfeeding. It explains why it is unclear if the medication passes through breast milk, why no human studies have been done, and what to discuss with your healthcare provider.
This eMedTV page explores the issues surrounding generic Caduet and its availability. Although the patent is due to expire in 2018, a court case may rule the patent invalid. The possibility to minimize drug costs by taking Caduet is also discussed.
| Referring Pages | Articles |
